Evidence map›Paper›PMID 33541996›Full record

ArticleBMJ case reports2021

Primary versus secondary nature of mesenteric neuroendocrine tumours.

Ariel Park, Alicia Martin, Ramos Carlos, Vladimir Neychev

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ariel ParkUniversity of Central Florida College of Medicine, Orlando, Florida, USA.
Alicia MartinUniversity of Central Florida College of Medicine, Orlando, Florida, USA.
Ramos CarlosDepartment of Pathology, Central Florida Regional Hospital, Sanford, Florida, USA.
Vladimir NeychevDepartment of Clinical Sciences, University of Central Florida College of Medicine, Orlando, Florida, USA Vladimir.Neychev@ucf.edu.
Florida College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine tumours (NETs) are rare group of malignancy that originate from neuroendocrine cells present throughout the body. Most patients with NET first present with symptoms associated with metastasis, and up to 20% of patients have unknown primary site of tumour. Most common metastatic sites for small intestine NETs (SI-NETs) are the locoregional lymph nodes and liver. Although mesenteric metastasis through direct extension or lymphatic spread from SI-NETs is common, mesenteric extranodal involvement is extremely rare, and its biology and primary versus secondary nature are not well understood. Due to their small size and location, SI-NETs are frequently undetected on anatomical imaging or indium-111-pentetreotide single-photon emission computed tomography/CT (Octreoscan) and are difficult to be found via endoscopy. Gallium-68-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-octreotate positron emission tomography (

Indexed as

Positron Emission Tomography Computed TomographyTomography, X-Ray ComputedAgedHumansIntestinal NeoplasmsMaleNeoplasms, Unknown PrimaryNeuroendocrine TumorsOctreotideOrganometallic CompoundsRadiopharmaceuticalsGa(III)-DOTATOCOctreotideOrganometallic CompoundsRadiopharmaceuticalsendocrine cancergastrointestinal surgerygeneral surgerysurgerysurgical oncology

Identifiers

PMID33541996
PMCPMC7868254
OpenAlexW3127507504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.